Business

Analysts Outlook: Cytrx Cp (NASDAQ:CYTR)

Cytrx Cp (NASDAQ:CYTR) shares traded -3.19% down during most recent session to reach at the closing price of $0.85. The stock exchanged hands 10.47 Million shares versus average trading capacity of 5.94 Million shares, yielding a market cap of $107.82 Million. Wall Street analysts covering the stock are projecting that the stock will reach $4 within the next 52-weeks. The mean target projections are based on 1 opinions.

Taking a broader look brokerage firms’ analysts on the street with an expectant view have Cytrx Cp (NASDAQ:CYTR) high price target of $4 and with a conservative view have low price target of $4.

Jefferies “Initiates Coverage on” Cytrx Cp (NASDAQ:CYTR) in a research note issued to investors on 1/07/16 to Hold with price target of $.

Additionally on 4/21/15 FBR Capital “Initiates Coverage on” Cytrx Cp (NASDAQ:CYTR) to Outperform setting price target at $8 and on 4/17/15 Oppenheimer “Initiates Coverage on” the stock to Outperform at $10. Furthermore on 1/23/14 Aegis Capital “Maintained” the stock to Buy at $12.

On the other hand the company has Relative Strength Index (RSI 14) of 72.07 along with Average True Range (ATR 14) of 0.09, Consequently Cytrx Cp (NASDAQ:CYTR)’s weekly and monthly volatility is 20.55%, 11.47% respectively. The company’s beta value is at 2.34.

In terms of Buy, Sell or Hold recommendations, Cytrx Cp (NASDAQ:CYTR) has analysts’ mean recommendation of 2. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.

Previously Cytrx Cp (NASDAQ:CYTR) reported $-0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $-0.11 by $0.05. The company posted an earnings surprise of 0.455%.

Currently Cytrx Cp (NASDAQ:CYTR)’s shares owned by insiders are 1.6%, whereas shares owned by institutional owners are 11.3%. However the six-month change in the insider ownership was recorded 0%, as well as three-month change in the institutional ownership was recorded -33.21%.

Cytrx Cp (NASDAQ:CYTR) 52-week high price stands at $3.02 and low price stands at $0.36, its price distance from 52-week high is -71.85% while its distance from 52-week low price is 135.46%. The stock hit its 52-week high on 06/03/16, and 52-week low on 12/28/16.

Cytrx Cp (NASDAQ:CYTR)’s trailing twelve month revenues are $200000, whereas its price to sales ratio for the same period is 539.11. Its book value per share for the most recent quarter is $0.13 while its price to book ratio for the same period is 6.54, as for as the company’s cash per share for the most recent quarter is $0, however its price to cash per share ratio for the same period is 0. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0.

Previous ArticleNext Article